Latest News

8th January, 2016

OncoImmunity collaborates with a cancer therapeutic vaccine company

OncoImmunity enters into a collaboration with a vaccine company to identify immunogenic neoantigen signatures in a vaccine clinical trial, in combination checkpoint inhibitor therapy.

Please enable your browser to accept cookies and refresh this page to enjoy the best experience from this website and to dismiss this message.
In order to provide you with the best online experience this website uses cookies. By using our website, you agree to our use of cookies.OK